1 false false false false false false false false false false true false false false false false false No description of principal activity 2023-07-01 Sage Accounts Production Advanced 2023 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 09639540 2023-07-01 2024-06-30 09639540 2024-06-30 09639540 2023-06-30 09639540 2022-07-01 2023-06-30 09639540 2023-06-30 09639540 2022-06-30 09639540 bus:Director1 2023-07-01 2024-06-30 09639540 core:WithinOneYear 2024-06-30 09639540 core:WithinOneYear 2023-06-30 09639540 bus:Micro-entities 2023-07-01 2024-06-30 09639540 bus:AuditExemptWithAccountantsReport 2023-07-01 2024-06-30 09639540 bus:SmallCompaniesRegimeForAccounts 2023-07-01 2024-06-30 09639540 bus:PrivateLimitedCompanyLtd 2023-07-01 2024-06-30 09639540 bus:FullAccounts 2023-07-01 2024-06-30
COMPANY REGISTRATION NUMBER: 09639540
THAMES VALLEY ANAESTHESIA LTD
Filleted Unaudited Financial Statements
30 June 2024
THAMES VALLEY ANAESTHESIA LTD
Statement of Financial Position
30 June 2024
2024
2023
£
£
Current assets
48,034
33,169
Creditors: amounts falling due within one year
8,312
20,276
--------
--------
Net current assets
39,722
12,893
--------
--------
Total assets less current liabilities
39,722
12,893
Accruals and deferred income
864
720
--------
--------
38,858
12,173
--------
--------
Capital and reserves
38,858
12,173
--------
--------
Notes to the financial statements
1. Employee numbers
The average number of persons employed by the company during the year amounted to 1 (2023: 1 ).
2. Director's advances, credits and guarantees
For the year ending 30 June 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 30 September 2024 , and are signed on behalf of the board by:
Dr A Cumberworth
Director
Company registration number: 09639540
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 35 Ruddlesway, Windsor, SL4 5SF.